Hyperactivity of Mek in TNS1 knockouts leads to potential treatments for cystic kidney diseases

Zong Ye Wu, Chun Lung Chiu, Ethan Lo, Yuh Ru Julie Lee, Soichiro Yamada, Su Hao Lo

Research output: Contribution to journalArticle

Abstract

Cystic kidney disease is the progressive development of multiple fluid-filled cysts that may severely compromise kidney functions and lead to renal failure. TNS1 (tensin-1) knockout mice develop cystic kidneys and die from renal failure. Here, we have established TNS1-knockout MDCK cells and applied 3D culture system to investigate the mechanism leading to cyst formation. Unlike wild-type MDCK cells, which form cysts with a single lumen, TNS1-knockout cysts contain multiple lumens and upregulated Mek/Erk activities. The multiple lumen phenotype and Mek/Erk hyperactivities are rescued by re-expression of wild-type TNS1 but not the TNS1 mutant lacking a fragment essential for its cell–cell junction localization. Furthermore, Mek inhibitor treatments restore the multiple lumens back to single lumen cysts. Mek/Erk hyperactivities are also detected in TNS1-knockout mouse kidneys. Treatment with the Mek inhibitor trametinib significantly reduces the levels of interstitial infiltrates, fibrosis and dilated tubules in TNS1-knockout kidneys. These studies establish a critical role of subcellular localization of TNS1 in suppressing Mek/Erk signaling and maintaining lumenogenesis, and provide potential therapeutic strategies by targeting the Mek/Erk pathway for cystic kidney diseases.

Original languageEnglish (US)
Article number871
JournalCell Death and Disease
Volume10
Issue number12
DOIs
StatePublished - Dec 1 2019

Fingerprint

Cystic Kidney Diseases
Cysts
Madin Darby Canine Kidney Cells
Kidney
Knockout Mice
Renal Insufficiency
Cyst Fluid
Tensins
Fibrosis
Phenotype

ASJC Scopus subject areas

  • Immunology
  • Cellular and Molecular Neuroscience
  • Cell Biology
  • Cancer Research

Cite this

Hyperactivity of Mek in TNS1 knockouts leads to potential treatments for cystic kidney diseases. / Wu, Zong Ye; Chiu, Chun Lung; Lo, Ethan; Lee, Yuh Ru Julie; Yamada, Soichiro; Lo, Su Hao.

In: Cell Death and Disease, Vol. 10, No. 12, 871, 01.12.2019.

Research output: Contribution to journalArticle

Wu, Zong Ye ; Chiu, Chun Lung ; Lo, Ethan ; Lee, Yuh Ru Julie ; Yamada, Soichiro ; Lo, Su Hao. / Hyperactivity of Mek in TNS1 knockouts leads to potential treatments for cystic kidney diseases. In: Cell Death and Disease. 2019 ; Vol. 10, No. 12.
@article{c4e5978f26194394ae529514c0ac312f,
title = "Hyperactivity of Mek in TNS1 knockouts leads to potential treatments for cystic kidney diseases",
abstract = "Cystic kidney disease is the progressive development of multiple fluid-filled cysts that may severely compromise kidney functions and lead to renal failure. TNS1 (tensin-1) knockout mice develop cystic kidneys and die from renal failure. Here, we have established TNS1-knockout MDCK cells and applied 3D culture system to investigate the mechanism leading to cyst formation. Unlike wild-type MDCK cells, which form cysts with a single lumen, TNS1-knockout cysts contain multiple lumens and upregulated Mek/Erk activities. The multiple lumen phenotype and Mek/Erk hyperactivities are rescued by re-expression of wild-type TNS1 but not the TNS1 mutant lacking a fragment essential for its cell–cell junction localization. Furthermore, Mek inhibitor treatments restore the multiple lumens back to single lumen cysts. Mek/Erk hyperactivities are also detected in TNS1-knockout mouse kidneys. Treatment with the Mek inhibitor trametinib significantly reduces the levels of interstitial infiltrates, fibrosis and dilated tubules in TNS1-knockout kidneys. These studies establish a critical role of subcellular localization of TNS1 in suppressing Mek/Erk signaling and maintaining lumenogenesis, and provide potential therapeutic strategies by targeting the Mek/Erk pathway for cystic kidney diseases.",
author = "Wu, {Zong Ye} and Chiu, {Chun Lung} and Ethan Lo and Lee, {Yuh Ru Julie} and Soichiro Yamada and Lo, {Su Hao}",
year = "2019",
month = "12",
day = "1",
doi = "10.1038/s41419-019-2119-7",
language = "English (US)",
volume = "10",
journal = "Cell Death and Disease",
issn = "2041-4889",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Hyperactivity of Mek in TNS1 knockouts leads to potential treatments for cystic kidney diseases

AU - Wu, Zong Ye

AU - Chiu, Chun Lung

AU - Lo, Ethan

AU - Lee, Yuh Ru Julie

AU - Yamada, Soichiro

AU - Lo, Su Hao

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Cystic kidney disease is the progressive development of multiple fluid-filled cysts that may severely compromise kidney functions and lead to renal failure. TNS1 (tensin-1) knockout mice develop cystic kidneys and die from renal failure. Here, we have established TNS1-knockout MDCK cells and applied 3D culture system to investigate the mechanism leading to cyst formation. Unlike wild-type MDCK cells, which form cysts with a single lumen, TNS1-knockout cysts contain multiple lumens and upregulated Mek/Erk activities. The multiple lumen phenotype and Mek/Erk hyperactivities are rescued by re-expression of wild-type TNS1 but not the TNS1 mutant lacking a fragment essential for its cell–cell junction localization. Furthermore, Mek inhibitor treatments restore the multiple lumens back to single lumen cysts. Mek/Erk hyperactivities are also detected in TNS1-knockout mouse kidneys. Treatment with the Mek inhibitor trametinib significantly reduces the levels of interstitial infiltrates, fibrosis and dilated tubules in TNS1-knockout kidneys. These studies establish a critical role of subcellular localization of TNS1 in suppressing Mek/Erk signaling and maintaining lumenogenesis, and provide potential therapeutic strategies by targeting the Mek/Erk pathway for cystic kidney diseases.

AB - Cystic kidney disease is the progressive development of multiple fluid-filled cysts that may severely compromise kidney functions and lead to renal failure. TNS1 (tensin-1) knockout mice develop cystic kidneys and die from renal failure. Here, we have established TNS1-knockout MDCK cells and applied 3D culture system to investigate the mechanism leading to cyst formation. Unlike wild-type MDCK cells, which form cysts with a single lumen, TNS1-knockout cysts contain multiple lumens and upregulated Mek/Erk activities. The multiple lumen phenotype and Mek/Erk hyperactivities are rescued by re-expression of wild-type TNS1 but not the TNS1 mutant lacking a fragment essential for its cell–cell junction localization. Furthermore, Mek inhibitor treatments restore the multiple lumens back to single lumen cysts. Mek/Erk hyperactivities are also detected in TNS1-knockout mouse kidneys. Treatment with the Mek inhibitor trametinib significantly reduces the levels of interstitial infiltrates, fibrosis and dilated tubules in TNS1-knockout kidneys. These studies establish a critical role of subcellular localization of TNS1 in suppressing Mek/Erk signaling and maintaining lumenogenesis, and provide potential therapeutic strategies by targeting the Mek/Erk pathway for cystic kidney diseases.

UR - http://www.scopus.com/inward/record.url?scp=85075114152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075114152&partnerID=8YFLogxK

U2 - 10.1038/s41419-019-2119-7

DO - 10.1038/s41419-019-2119-7

M3 - Article

C2 - 31740667

AN - SCOPUS:85075114152

VL - 10

JO - Cell Death and Disease

JF - Cell Death and Disease

SN - 2041-4889

IS - 12

M1 - 871

ER -